109 related articles for article (PubMed ID: 22207519)
1. Wnt, osteosarcoma, and future therapy.
Hoang BH
J Am Acad Orthop Surg; 2012 Jan; 20(1):58-9. PubMed ID: 22207519
[No Abstract] [Full Text] [Related]
2. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
[TBL] [Abstract][Full Text] [Related]
3. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
[TBL] [Abstract][Full Text] [Related]
4. Degraded iota-carrageenan can induce apoptosis in human osteosarcoma cells via the Wnt/β-catenin signaling pathway.
Jin Z; Han YX; Han XR
Nutr Cancer; 2013; 65(1):126-31. PubMed ID: 23368922
[TBL] [Abstract][Full Text] [Related]
5. The Wnt signaling pathway: implications for therapy in osteosarcoma.
McQueen P; Ghaffar S; Guo Y; Rubin EM; Zi X; Hoang BH
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1223-32. PubMed ID: 21916576
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
7. Wnt pathway activation, cell migration, and lipid uptake is regulated by low-density lipoprotein receptor-related protein 5 in human macrophages.
Borrell-Pagès M; Romero JC; Juan-Babot O; Badimon L
Eur Heart J; 2011 Nov; 32(22):2841-50. PubMed ID: 21398644
[TBL] [Abstract][Full Text] [Related]
8. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
9. c-Jun Is critical for the progression of osteosarcoma: proof in an orthotopic spontaneously metastasizing model.
Dass CR; Khachigian LM; Choong PF
Mol Cancer Res; 2008 Aug; 6(8):1289-92. PubMed ID: 18708361
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of zoledronic acid against human osteosarcoma cells.
Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
[TBL] [Abstract][Full Text] [Related]
11. [Apoptosis-related gene expression and its clinical significance of human osteosarcoma].
Wu X; Chen ZR; Zhang GJ
Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):678-81. PubMed ID: 15777507
[TBL] [Abstract][Full Text] [Related]
12. Is CDK9 a promising target for both primary and metastatic osteosarcoma?
Qin JJ
EBioMedicine; 2019 Feb; 40():27-28. PubMed ID: 30651218
[No Abstract] [Full Text] [Related]
13. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
15. The association of P-glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma. A meta-analysis.
Pakos EE; Ioannidis JP
Cancer; 2003 Aug; 98(3):581-9. PubMed ID: 12879476
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
Zou Y; Yang J; Jiang D
Mol Med Rep; 2015 Nov; 12(5):7221-6. PubMed ID: 26398440
[TBL] [Abstract][Full Text] [Related]
17. [Neoadjuvant chemotherapy and cyclo-oxygenase pathway of arachidonic acid metabolism in osteogenic sarcoma].
Kushlinskiĭ ; Trapeznikov NN; Solov'ev IuN; Aliev MD; Kasumov ChM; Shikhammedov NA; Khatyrev SA
Biull Eksp Biol Med; 1996 Nov; 122(11):551-6. PubMed ID: 8998350
[No Abstract] [Full Text] [Related]
18. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
Ferracini R; Di Renzo MF; Scotlandi K; Baldini N; Olivero M; Lollini P; Cremona O; Campanacci M; Comoglio PM
Oncogene; 1995 Feb; 10(4):739-49. PubMed ID: 7862451
[TBL] [Abstract][Full Text] [Related]
19. The effect of chemotherapy on osteosarcoma.
Klein Nagelvoort HM; Kubat K; van Horn J
Ital J Orthop Traumatol; 1992; 18(3):379-84. PubMed ID: 1308883
[TBL] [Abstract][Full Text] [Related]
20. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
